Research and clinical interest in inflammation and fibrosis in chronic inflammatory liver diseases including cirrhosis complications of ascites, variceal bleeding, encephalopathy and primary liver cancer. Head of ENETS Center of Excellence for patients with neuroendocrine tumors.       

Intestinal failure, clinical nutrition, faecal microbiota transplantation (FMT). Three rapidly evolving disciplines and the core of my clinical and academic work. I work as the lead of our intestinal failure unit and as the project leader of Centre for FMT at Aarhus University Hospital (CEFTA).     

I am a clinician-researcher specializing in epidemiologic research in liver disease—“hepato-epidemiology”. Much of my research uses data from our nationwide healthcare registries, and my research areas are alcohol-related liver disease and cirrhosis and its complications, particularly liver cancer.    

Professor in gastroenterology, special interest area: neurogastroenterology, i.e. the interaction between the nerve system and the gut. My current main focus areas are intestinal neuropathy in diabetes mellitus and chronic bowel symptoms caused by treatment of cancer in the pelvic organs.

A major focus of interest is the metabolic events that lead to hepatic encephalopathy in patients with liver dysfunction. Another is the genetic background, pathophysiology and treatment of intrahepatic cholestatic conditions. Recently, we built a research group with focus on Wilson Disease.

My personal main interest is liver cirrhosis. My research is a mix of clinical, basic, and epidemiological. Hepatic encephalopathy is a central interest, as is disturbances in nitrogen metabolism, particularly in urea urea synthesis, and the clinical course of cirrhosis and prognostic factors.     

Associate Professors

Patients with liver- or gut diseases are the main focus in our research. Topics include fatigue, worries, health-related quality of life, adherence, and health literacy. Also broader topics like patient involvement, development of care, self-management, and equality in health are studied.

We work with neuroendocrine tumors and sarcopenia in both cancer and cirrhosis patients. We aim to opitimze treatment of NET patients by designing personalized treatments with peptide receptor radio therapy (dosimetry based PRRT). Head of ENETS Center of Excellence for patients with neuroendocrine tumors.

Work with Inflammatory Bowel Disease (IBD). Main research interests is anal fistulas in patients with Crohn´s Disease and treatment of these with autologous adipose tissue injections, and stem cell treatment of IBD in general.

We aim to strengthen colorectal research by applying high quality clinical epidemiological methods into the field of surgery. We want to improve the understanding of colorectal diseases, thereby enhancing shared clinical decision-making, treatment, and patient guidance.

Main research focuses on gastrointestinal late sequelae to cancer in the pelvic organs, medical education, and intestinal failure. This is persued in clinical studies observing and experimenting with new investigation methods or treatment modalities and seeking new ways to optimise medical learning.

Our research is focused on immune mediated liver injury and the consequences of hepatic inflammation. Through basic research we study pathogenic mechanisms, biomarkers and new treatments. We also have an equally important focus on rare liver diseases especially Wilson disease.     

My research focuses on studying the pathophysiological impact of inflammation on organ injury in liver diseases ranging from liver cirrhosis to alcoholic hepatitis and non-alcoholic fatty liver disease. This is pursued through experimental and clinical studies. 

As consultant in hepatology I focus on patients with liver cirrhosis and especially liver transplantation. In addition, I am responsible for patients with primary liver cancer and head our multidisciplinary tumor board. My reasearch is focused on these patient groups investigating new methods for diagnosis and prognosis including novel biomarkers and imaging methods. Further, implementation of novel treatment modalities including proton, radiation and immune therapy. My research is multidisciplinary and involves local, national and international collaborations.